Zerax

Zerax is engineering the next evolution of human interface with pharmacology. We are developing precision systems designed to enhance how compounds interact with the body—intelligently, adaptively, and in sync with real physiological demands. Our first device, now fully defined at the engineering level (SOW completed), introduces a new architecture for compound delivery: programmable, modular, and built for high-stakes environments. Zerax is a biotechnology company focused on expanding the limits of human performance, recovery, and resilience—across clinical, operational, and extreme conditions. Our work is guided by three principles: precision, control, and real-world viability. While current development targets regulated compounds, the platform is designed to support future applications at the intersection of biology, systems engineering, and human performance. We are building infrastructure—not speculation—for how the body engages with chemistry at scale.